ETS-1 proto-oncogene as a key newcomer molecule to predict invasiveness in laryngeal carcinoma

Pathology Research and Practice

Volumn 207, Issue 10, 2011, Pages 628-633

  Calli, Aylin Orgen ^a   Sari, Aysegul ^a   Cakalagaoglu, Fulya ^a   Altinboga, Aysegul Aksoy ^a   Oncel, Semih ^a  

^a Izmir Ataturk Training and Research Hospital   (Turkey)

Author keywords

ETS 1 oncoprotein; Immunohistochemistry; Invasiveness; Larynx; Squamous carcinoma

Indexed keywords

TRANSCRIPTION FACTOR ETS 1;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEIN C-ETS-1;

EID: 80755190089     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.07.010     Document Type: Article

References (43)

1. Alipov G., Nakayama T., Ito M., et al. Overexpression of ETS-1 proto-oncogene in latent and clinical prostatic carcinomas. Histopathology 2005, 46(2):202-208.
2. Almadori G., Bussu F., Cadoni G., et al. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur. J. Cancer 2005, 41(5):683-693.
3. Behrens P., Rothe M., Wellmann A., et al. The ETS-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J. Pathol. 2001, 194:43-50.
4. Behrens P., Rothe M., Florin A., et al. Invasive properties of serous human epithelial ovarian tumors are related to ETS-1, MMP-1 and MMP-9 expression. Int. J. Mol. Med. 2001, 8:149-154.
5. Bolon I., Gouyer V., Devouassoux M., et al. Expression of c-ETS-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am. J. Pathol. 1995, 147(5):1298-1310.
6. Buggy Y., Maguire T.M., McGreal G., et al. Overexpression of the ETS-1 transcription factor in human breast cancer. Br. J. Cancer 2004, 91(7):1308-1315.
7. Davidson B., Reich R., Goldberg I., et al. ETS-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin. Cancer Res. 2001, 7:551-557.
8. Dittmer J. The biology of the ETS-1 proto-oncogene. Mol. Cancer 2003, 2:1-21.
9. Endo K., Shirai A., Furukawa M., et al. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma. Hum. Pathol. 2006, 37(8):1111-1116.
10. Fleskens S., Slootweg P. Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility. Head Neck Oncol. 2009, 11(1):11.
11. Fujimoto J., Aoki I., Toyoki H., et al. Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers. Ann. Oncol. 2002, 13:1598-1604.
12. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 2003, 260:502-508.
13. Hida K., Shindoh M., Yoshida K., et al. Expression of E1AF, an ETS-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinoma. Oral Oncol. 1997, 33(6):426-430.
14. Horváth B., Hegyesi H., Nagy P., et al. Expression of ETS-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ETS-1 and matrix metalloproteinase-3. Head Neck 2005, 27(7):585-596.
15. Ito T., Nakayama T., Ito M., et al. Expression of the ETS-1 proto-oncogene in human pancreatic carcinoma. Mod. Pathol. 1998, 11(2):209-215.
16. Ito Y., Miyoshi E., Takeda T., et al. ETS-1 expression in extrahepatic bile duct carcinoma and cholangiocellular carcinoma. Oncology 2000, 58(3):248-252.
17. Ito Y., Miyoshi E., Takeda T., et al. Expression and possible role of ETS-1 in hepatocellular carcinoma. Am. J. Clin. Pathol. 2000, 114(5):719-725.
18. Kanda K., Nakayama T., Onizuka S., et al. Expression of the ETS-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma. Hepatogastroenterology. 2002, 49(45):747-751.
19. Katayama S., Nakayama T., Ito M., et al. Expression of the ETS-1 proto-oncogene in human breast carcinoma: differential expression with histological grading and growth pattern. Histol. Histopathol. 2005, 20(1):119-126.
20. Keehn C.A., Smoller B.R., Morgan M.B. Expression of the ETS-1 proto-oncogene in melanocytic lesions. Mod. Pathol. 2003, 16(8):772-777.
21. Kitange G., Tsunoda K., Anda T., et al. Immunohistochemical expression of ETS-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas. Cancer 2000, 89(11):2292-2300.
22. Kitange G., Kishikawa M., Nakayama T., et al. Expression of the ETS-1 proto-oncogene correlates with malignant potential in human astrocytic tumors. Mod. Pathol. 1999, 12(6):618-626.
23. Lewin B. Oncogenic conversion by regulatory changes in transcription factors. Cell 1991, 64:303.
24. Loyo M., Pai S.I. The molecular genetics of laryngeal cancer. Otolaryngol. Clin. North Am. 2008, 41(4):657-672.
25. Naito S., Shimizu K., Nakashima M., et al. Overexpression of ETS-1 transcription factor in angiosarcoma of the skin. Pathol. Res. Pract. 2000, 196(2):103-109.
26. Nakada M., Yamashita J., Okada Y., et al. ETS-1 positivity regulates expression of urokinase-type plasminogen activator and invasiveness of astrocytic tumors. J. Neuropathol. Exp. Neurol. 1999, 58:329-334.
27. Nakayama T., Ito M., Ohtsuru A., et al. Expression of the ETS-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion. Am. J. Pathol. 1996, 149(6):1931-1939.
28. Nakayama T., Ito M., Ohtsuru A., et al. Expression of the ETS-1 proto-oncogene in human colorectal carcinoma. Mod. Pathol. 2001, 14(5):415-422.
29. Nakayama T., Yoshizaki A., Naito S., et al. Expression of ETS-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas. World J. Gastroenterol. 2006, 12(11):1743-1746.
30. Oikawa T., Yamada T. Molecular biology of the ETS family of transcription factors. Gene 2003, 16:11-34.
31. Pande P., Mathur M., Shukla N.K., et al. ETS-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas. J. Pathol. 1999, 189(1):40-45.
32. Saeki H., Kuwano H., Kawaguchi H., et al. Expression of ETS-1 transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus. Cancer 2000, 89(8):1670-1676.
33. Sasaki H., Yukiue H., Moiriyama S., et al. Clinical significance of matrix metalloproteinase-7 and ETS-1 gene expression in patients with lung cancer. J. Surg. Res. 2001, 101(2):242-247.
34. Span P.N., Manders P., Heuvel J.J., et al. Expression of the transcription factor ETS-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 2002, 21:8506-8509.
35. Takai N., Miyazaki T., Fujisawa K., et al. Expression of c-ETS-1 is associated with malignant potential in endometrial carcinoma. Cancer 2000, 89(10):2059-2067.
36. Takai N., Miyazaki T., Nishida M., et al. c-ETS-1 is a promising marker in epithelial ovarian cancer. Int. J. Mol. Med. 2002, 9:287-292.
37. Takanami I., Takeuchi K., Karuke M. Expression of ETS-1 is correlated with urokinase-type plasminogen activator and poor prognosis in pulmonary adenocarcinoma. Tumour Biol. 2001, 22(4):205-210.
38. Thompson L.D.R., Wenig B.M., Kornblut A.D. Pharyngitis. Head and Neck Surgery - Otolaryngology 1998, 655-669. Lippincott-Raven, Philadelphia, PA. 2nd ed. B.J. Bailey (Ed.).
39. Trojanowska M. ETS factors and regulation of the extracellular matrix. Oncogene 2000, 19:6464-6471.
40. Tuszynski G.P., Wang T.N., Berger D. Adhesive proteins and the hematogenous spread of cancer. Acta Haematol. 1997, 97:29-39.
41. Vynios D.H., Theocharis D.A., Papageorgakopoulou N., et al. Biochemical changes of extracellular proteoglycans in squamous cell laryngeal carcinoma. Connect. Tissue Res. 2008, 49(3):239-243.
42. Yamaguchi E., Nakayama T., Nanashima A., et al. ETS-1 proto-oncogene as a potential predictor for poor prognosis of lung adenocarcinoma. Tohoku J. Exp. Med. 2007, 213(1):41-50.
43. Yu Y., Zhang Y.C., Zhang W.Z., et al. ETS-1 as a marker of malignant potential in gastric carcinoma. World J. Gastroenterol. 2003, 9(10):2154-2159.